ZNF623
gene geneOn this page
Also known as KIAA0628
Summary
ZNF623 (zinc finger protein 623, HGNC:29084) is a protein-coding gene on chromosome 8q24.3, encoding Zinc finger protein 623 (O75123). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 9831 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 60 total
- MANE Select transcript:
NM_001261843
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29084 |
| Approved symbol | ZNF623 |
| Name | zinc finger protein 623 |
| Location | 8q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA0628 |
| Ensembl gene | ENSG00000183309 |
| Ensembl biotype | protein_coding |
| Entrez | 9831 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 16 protein_coding
ENST00000458270, ENST00000501748, ENST00000526926, ENST00000857826, ENST00000857827, ENST00000857828, ENST00000857829, ENST00000857830, ENST00000857831, ENST00000929455, ENST00000929456, ENST00000929457, ENST00000929458, ENST00000929459, ENST00000950233, ENST00000950234
RefSeq mRNA: 3 — MANE Select: NM_001261843
NM_001082480, NM_001261843, NM_014789
CCDS: CCDS34957, CCDS47931
Canonical transcript exons
ENST00000526926 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002144416 | 143636019 | 143636145 |
| ENSE00003899615 | 143649898 | 143653730 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 86.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.2839 / max 87.0869, expressed in 1773 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 91415 | 11.2839 | 1773 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 86.31 | gold quality |
| ganglionic eminence | UBERON:0004023 | 85.61 | gold quality |
| ventricular zone | UBERON:0003053 | 83.34 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.10 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.52 | gold quality |
| islet of Langerhans | UBERON:0000006 | 82.32 | gold quality |
| stromal cell of endometrium | CL:0002255 | 81.89 | gold quality |
| endometrium | UBERON:0001295 | 80.96 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.30 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 80.23 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 79.72 | gold quality |
| corpus callosum | UBERON:0002336 | 79.66 | gold quality |
| colonic epithelium | UBERON:0000397 | 79.52 | gold quality |
| muscle tissue | UBERON:0002385 | 79.13 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 79.09 | gold quality |
| tonsil | UBERON:0002372 | 79.04 | gold quality |
| urinary bladder | UBERON:0001255 | 78.74 | gold quality |
| adrenal tissue | UBERON:0018303 | 78.63 | gold quality |
| muscle of leg | UBERON:0001383 | 78.08 | gold quality |
| leukocyte | CL:0000738 | 78.07 | gold quality |
| gastrocnemius | UBERON:0001388 | 77.99 | gold quality |
| monocyte | CL:0000576 | 77.81 | gold quality |
| ovary | UBERON:0000992 | 77.59 | gold quality |
| granulocyte | CL:0000094 | 77.58 | gold quality |
| rectum | UBERON:0001052 | 77.46 | gold quality |
| pancreas | UBERON:0001264 | 77.42 | gold quality |
| lymph node | UBERON:0000029 | 77.32 | gold quality |
| popliteal artery | UBERON:0002250 | 77.29 | gold quality |
| prefrontal cortex | UBERON:0000451 | 77.27 | gold quality |
| tibial artery | UBERON:0007610 | 77.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.04 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2497.1 | ZNF623 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605368
miRNA regulators (miRDB)
65 targeting ZNF623, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-1255A | 99.74 | 68.09 | 744 |
| HSA-MIR-1255B-5P | 99.74 | 68.16 | 741 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-7161-5P | 99.68 | 68.92 | 1592 |
| HSA-MIR-3934-5P | 99.67 | 64.04 | 846 |
| HSA-MIR-466 | 99.67 | 70.85 | 2863 |
| HSA-MIR-4804-3P | 99.65 | 67.78 | 866 |
| HSA-MIR-548U | 99.65 | 67.78 | 1463 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-183-3P | 99.41 | 69.41 | 1598 |
| HSA-MIR-5697 | 99.39 | 67.74 | 1249 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp623 | ENSMUSG00000050846 |
| rattus_norvegicus | Zfp623 | ENSRNOG00000009302 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 623 — O75123 (reviewed: O75123)
All UniProt accessions (1): O75123
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O75123-1 | 1 | yes |
| O75123-2 | 2 |
RefSeq proteins (3): NP_001075949, NP_001248772, NP_055604 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (21 total): zinc finger region 13, region of interest 2, compositionally biased region 2, chain 1, cross-link 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75123-F1 | 71.83 | 0.37 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 445
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 114 (showing top):
BROWNE_HCMV_INFECTION_6HR_DN, GENTILE_RESPONSE_CLUSTER_D3, ONKEN_UVEAL_MELANOMA_UP, GENTILE_UV_HIGH_DOSE_DN, DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, DAZARD_RESPONSE_TO_UV_NHEK_UP, TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C, JOHNSTONE_PARVB_TARGETS_2_DN, chr8q24, SMIRNOV_RESPONSE_TO_IR_6HR_UP, OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP, STK33_NOMO_DN
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
240 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF623 | C19orf25 | Q9UFG5 | 520 |
| ZNF623 | ZHX1-C8orf76 | Q96EF9 | 479 |
| ZNF623 | POP1 | Q99575 | 479 |
| ZNF623 | C8orf76 | Q96K31 | 474 |
| ZNF623 | TIGD5 | Q53EQ6 | 449 |
| ZNF623 | ARHGAP39 | Q9C0H5 | 447 |
| ZNF623 | COMMD5 | Q9GZQ3 | 447 |
| ZNF623 | C14orf180 | Q8N912 | 439 |
| ZNF623 | C8orf33 | Q9H7E9 | 435 |
| ZNF623 | SACK1H | Q6ZRV2 | 394 |
| ZNF623 | PUSL1 | Q8N0Z8 | 377 |
| ZNF623 | YDJC | A8MPS7 | 376 |
| ZNF623 | ELMOD3 | Q96FG2 | 374 |
| ZNF623 | LRRC14 | Q15048 | 373 |
| ZNF623 | NUDCD1 | Q96RS6 | 366 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF623 | ZNF76 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF623 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF623 | GAPDHS | psi-mi:“MI:0914”(association) | 0.350 |
| PRKAR1B | ZNF749 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC7A9 | CDC7 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF76 | ZNF623 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (12): ZNF623 (Affinity Capture-RNA), ZNF623 (Affinity Capture-RNA), ZNF623 (Two-hybrid), ZNF623 (Affinity Capture-RNA), ZNF623 (Two-hybrid), GAPDHS (Affinity Capture-MS), ZNF623 (Affinity Capture-MS), ARIH1 (Affinity Capture-MS), ZNF623 (Affinity Capture-MS), ZNF623 (Affinity Capture-MS), ZNF623 (Affinity Capture-RNA), ZNF623 (Affinity Capture-RNA)
ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, A6QLU5, B2RUI1, D3ZVT0, O14709, O43296, O75123, P10072, P15621, P17020, P17097, P51814, P85977, Q08ER8, Q0VGE8, Q14590, Q32KN0, Q3KQV3, Q4V8A8, Q5CZA5, Q5RBX0, Q5RCD9, Q5VIY5, Q61116, Q61967, Q6GQR8, Q6P9A3, Q6ZMS4, Q7TSH9, Q7TSI0, Q7Z3I7, Q86UD4, Q86WZ6, Q8BFS8, Q8IZ26, Q8N9F8, Q8TAF7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
60 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
287 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:143649734:GCT:G | donor_gain | 0.9800 |
| 8:143651340:AGTC:A | donor_gain | 0.9800 |
| 8:143651345:G:GG | donor_gain | 0.9800 |
| 8:143649751:GAGCT:G | donor_gain | 0.9700 |
| 8:143651338:GTA:G | donor_gain | 0.9700 |
| 8:143651344:A:AG | donor_gain | 0.9700 |
| 8:143651339:T:TA | donor_gain | 0.9600 |
| 8:143651419:G:GG | donor_gain | 0.9600 |
| 8:143649712:G:GT | donor_gain | 0.9400 |
| 8:143649753:GCT:G | donor_gain | 0.9400 |
| 8:143649761:T:TA | donor_gain | 0.9000 |
| 8:143649762:A:AA | donor_gain | 0.9000 |
| 8:143651341:G:GG | donor_gain | 0.8900 |
| 8:143651343:C:A | donor_gain | 0.8900 |
| 8:143649780:G:GT | donor_gain | 0.8800 |
| 8:143651418:A:AG | donor_gain | 0.8800 |
| 8:143649746:G:GT | donor_gain | 0.8600 |
| 8:143649857:T:G | donor_gain | 0.8600 |
| 8:143649861:G:GG | donor_gain | 0.8600 |
| 8:143651268:A:T | donor_gain | 0.8500 |
| 8:143649794:G:GT | donor_gain | 0.8300 |
| 8:143650020:G:GT | donor_gain | 0.8300 |
| 8:143649795:A:T | donor_gain | 0.8200 |
| 8:143651341:GTCA:G | donor_gain | 0.8200 |
| 8:143649693:TTAA:T | donor_gain | 0.8100 |
| 8:143651340:A:AG | donor_gain | 0.8000 |
| 8:143651184:A:T | donor_gain | 0.7800 |
| 8:143651252:GTGC:G | donor_gain | 0.7800 |
| 8:143649777:C:A | donor_gain | 0.7700 |
| 8:143649993:A:AG | donor_gain | 0.7700 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000014832 (8:143642877 C>A), RS1000054712 (8:143637465 C>G), RS1000097853 (8:143647366 G>A), RS1000107844 (8:143650807 T>G), RS1000387442 (8:143642666 T>C), RS1000451187 (8:143636390 G>C), RS1000476473 (8:143647884 C>T), RS1000703437 (8:143646112 G>A), RS1000714527 (8:143652186 G>A), RS1000762592 (8:143652629 A>T), RS1000772782 (8:143653387 T>G), RS1000989012 (8:143646274 C>T), RS1001056431 (8:143635384 G>C), RS1001084788 (8:143651980 G>A), RS1001164489 (8:143636336 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004750_21 | Squamous cell lung carcinoma | 5.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| urushiol | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Coumestrol | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| T-2 Toxin | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Vanadates | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD34 | HEK293 eGFP-ZNF623 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.